Deals Shaping The Medical Industry, November 2020
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
Executive Summary
This month’s column covers deals announced in November 2020. Data provided by Biomedtracker.
You may also be interested in...
J&J Forecasts Strong Pharma Growth In 2021, But No COVID-19 Vaccine Update
Data from a high-profile Phase III COVID-19 vaccine trial will be released the first week of February, management said.
OTC Sanitizer Firm In China On US Import Alert, Warned After Twice Missing On GMP Compliance
Yuyao YiJia Daily Chemical told FDA placed all drugs it manufactures on import alert in September because its methods and controls for manufacturing OTC sanitizers and other products do not appear to conform to current drug GMPs.
ATA Throws Weight Behind Renewed Telehealth Bill In New Session Of Congress
One of the first US telemed bills out of the gate in 2021 calls for permanently ending limits on CMS telehealth payments.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports